EMILY ARANYOS: Open Payments
NPI 1215484829 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 15 payments from 9 companies in 2025. Trend: 2023 $195 · 2024 $276 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Amgen Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: TRELEGY ELLIPTA, BREZTRI, KRYSTEXXA, KEVEYIS, Cologuard Collection Kit, QULIPTA, REXULTI, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
